SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641489-24-000037
Filing Date
2024-06-13
Accepted
2024-06-13 16:29:03
Documents
4
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1718310533.html 3  
1 FORM 3 wk-form3_1718310533.xml 3 1639
2 EX-24 powerofattorney-secfilin.htm EX-24 4218
3 GRAPHIC powerofattorney-secfilin001.jpg GRAPHIC 235268
4 GRAPHIC powerofattorney-secfilin002.jpg GRAPHIC 44527
  Complete submission text file 0001641489-24-000037.txt   393063
Mailing Address MYRIAD GENETICS 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
SPIEGELMAN DANIEL K (Reporting) CIK: 0001238403 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37524 | Film No.: 241041632

Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Issuer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)